Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GB-0998 vs Plasmapheresis in Generalized Myasthenia Gravis
NCT00515450Phase 3Completed
- Start
- Jul 2007
- Primary completion
- May 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of intravenous immunoglobulin G in myasthenia gravis (MG). Started Jul 2007; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on NCT00515450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00515450.